Captisol enabled furosemide (SQ Innovation)

N/A

Report date: 2026/02/14 20:00:22

Base Information

Drug NameCaptisol enabled furosemide (SQ Innovation)
Drug Alias NameCE FurosemideFuresomide 2.0Lasix OnyuLasix ONYUSQIN-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium-(potassium)-chloride cotransporter 2 inhibitorsGamma-aminobutyric acid A receptor antagonists
TargetsSodium-(potassium)-chloride cotransporter 2Gamma-aminobutyric acid A receptor
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsHeart Failure
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2024/12/16
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSq Innovation Inc
China Registration ClassN/A

Develop Information

Active CompaniesGerresheimer AG
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A